J&J Medical Connect
EDURANT®

(rilpivirine)

J&J Medical Connect

Connect with us

Connect with us

This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.

EDURANT® (rilpivirine)
Medical Information

Use of EDURANT in Coronavirus

Last Updated: 07/14/2026

SUMMARY

  • There are no prospective clinical studies that evaluated the efficacy and safety of EDURANT for the treatment of COVID-19.

Literature Search

A literature search of MEDLINE®, Embase®, BIOSIS Previews®, and Derwent Drug File (and/or other resources, including internal/external databases) pertaining to this topic was conducted on 03 January 2025. In-vitro studies, case reports, and retrospective studies were not summarized.

Would you like to clear and leave your conversation? Message history will be lost.